Literature DB >> 3159570

Sensitivity of urinary staphylococci to ciprofloxacin and acrosoxacin.

A F Kent, D C Speller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159570     DOI: 10.1007/bf02013582

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Acute cystitis in young women. Treatment with citrated nalidixic acid compared with co-trimoxazole.

Authors:  A V Butler; M J Cullen; M O Parry; D G Sylvester; D C Speller
Journal:  Practitioner       Date:  1983-05

2.  Antimicrobial susceptibility of Staphylococcus saprophyticus and urethral staphylococci.

Authors:  T J Marrie; C Kwan
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Letter: Oxolinic acid in urinary infections.

Authors:  P D Meers
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

4.  Urinary tract infection in young women, with special reference to Staphylococcus saprophyticus.

Authors:  W A Gillespie; M A Sellin; P Gill; M Stephens; L A Tuckwell; A L Hilton
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

5.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

6.  Does the addition of disinfectant to urine drainage bags prevent infection in catheterised patients?

Authors:  W A Gillespie; R A Simpson; J E Jones; L Nashef; C Teasdale; D C Speller
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

  6 in total
  2 in total

1.  New 4-quinolones in the treatment of urinary tract infections.

Authors:  J B Boerema
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

Review 2.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.